Bill Snyder

Max Joffe, PhD, left, P. Jeffrey Conn, PhD, and colleagues are studying a new class of antidepressants that may relieve symptoms more rapidly and with fewer side effects.
November 21, 2019

Study explores potential new class of antidepressants

Researchers at VUMC have taken a major step that could ultimately facilitate development of a new class of antidepressants which may relieve symptoms more rapidly and effectively and with fewer side effects than current medications.

From left, Qi Liu, PhD, Lori Coburn, MD, Gregor Neuert, PhD, Keith Wilson, MD, Ken Lau, PhD, and Bennett Landman, PhD, are leading VUMC’s contribution to the “gut cell atlas” program funded by the Leona M. and Harry B. Helmsley Charitable Trust.
November 20, 2019

Grant spurs effort to map biology of Crohn’s disease

VUMC has been awarded a three-year, $3 million grant to map — in unprecedented detail — the biology of Crohn’s disease.

November 18, 2019

Roden wins Schottenstein Prize from Ohio State University

Kathryn Edwards, MD, was honored for her contributions to pediatrics and vaccine research.
November 14, 2019

Edwards receives American Pediatric Society’s top award

Vanderbilt’s Kathryn Edwards, MD, is the recipient of the 2020 John Howland Award, the highest honor given by the American Pediatric Society (APS).

Brain image
November 14, 2019

Blueprint for treating epilepsy

Structural details of a protein that is essential to normal brain function could improve treatments for epilepsy and other seizure disorders.

November 5, 2019

Endotoxin shock protector

A novel tool developed by Vanderbilt scientists protects animals from endotoxin shock and can be used for mechanistic analyses of inflammation due to microbial and other insults.